在模拟的药物管理体验中利用药剂师的患者护理过程,为医学学习者提供药物管理体验
Jaime A Foushee1, David Eagerton2, Tommy Lindsey2
1Edward Via College of Osteopathic Medicine, Carolinas Campus, 350 Howard Street, Spartanburg, South Carolina 29303 USA.
American journal of pharmaceutical education
|February 15, 2026
概括
一个模拟的药物管理经验提高了医学学习者对药剂师患者护理流程 (PPCP) 的信心. 这种教育干预显著提高了学生有效管理药物的能力.
科学领域:
- 医学教育 医学教育
- 药理学 药理学是指药理学的学科.
- 患者护理 患者护理
背景情况:
- 药剂师的患者护理过程 (PPCP) 是药物管理的框架.
- 医学学习者需要有效的药物管理培训.
- 模拟学习环境提供了开发临床技能的机会.
研究的目的:
- 为医学学习者实施和评估模拟药物管理经验.
- 评估模拟对知识和对PPCP的信心的影响.
- 确定PPCP框架在模拟教育环境中的实用性.
主要方法:
- 医学二年级学生参加了两周期的模拟药物管理体验.
- 模拟包括与PPCP步骤一致的站点:收集,评估,计划,实施,监控.
- 调查前后测量了PPCP知识和信心,并使用非参数测试进行分析.
主要成果:
- 310名学生参与,基线PPCP熟悉率为24.5%.
- 在模拟后的所有PPCP步骤 (p<0.0001) 中观察到有统计学意义的信心增加.
- 利克特尺度信任度的中位数总和在整体上显著增加,并按PPCP阶段 (p<0.0001).
结论:
- 一个模拟的学习活动有效地利用了PPCP框架.
- 模拟提高了医学学习者的知识和对药物管理的信心.
- PPCP框架对于培训医疗专业学生在药物管理方面有价值.
相关概念视频
Pharmaceutical Poisoning: Potential Scenarios
15
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
15
Drug Administration and Therapy Phases: Overview
1.5K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.5K
Pharmacokinetic Models: Overview
2.2K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.2K
Dosage Regimens: Designs and Approaches
347
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
347
Drug Dosing: Geriatric Patients
281
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
281
Pharmacokinetic–Pharmacodynamic Relationship: Problems
18
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
18


